Liu DaGe, Kobayashi Takaaki, Onishi Akira, Furusawa Tadashi, Iwamoto Masaki, Suzuki Shunichi, Miwa Yuko, Nagasaka Takaharu, Maruyama Shoichi, Kadomatsu Kenji, Uchida Kazuharu, Nakao Akimasa
Department of Surgery II, Nagoya University School of Medicine, Nagoya, Japan.
Xenotransplantation. 2007 Jan;14(1):67-73. doi: 10.1111/j.1399-3089.2006.00365.x.
Although the successful production of alpha1,3-galactosyltransferase-knockout (GT-KO) pigs has increased expectations of clinical xenotransplantation, additional modifications of genetically engineered pigs are still being explored, because even GT-KO pigs are incapable of inhibiting the host's immunological response completely. One of the potential candidates is a complement-regulatory protein, such as human decay-accelerating factor (hDAF). However, there are few reports on how high the expression level of hDAF in pig cells would be required for suppression of complement activation. The purpose of this study was to examine the relationship between the level of hDAF expression and its inhibitory effect on human serum cytotoxicity.
An expression (pCAGGS) vector containing the hDAF gene was transfected into pig fibroblasts using an electroporation system (Gene Pulser II). Forty-eight to fifty-two hours after transfection, the cells were stained with FITC-labeled anti-hDAF antibody and then applied to the cell sorter. hDAF-transfected cells with various expression levels were collected by gating on fluorescence intensity. The level of hDAF expression was determined relative to that in human control endothelial cells. Collected cells expressing x1, x5, x10, x15 and x30 hDAF were incubated into 96-well plates for 16 h, and the cells were subjected to 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide (MTT) assay.
hDAF expression levels in transfected cells at the time of MTT assay (16 h after sorting) were comparable to those immediately after sorting. hDAF expression in pig cells five times higher than in human endothelial cells was effective in inhibiting complement-dependent cytotoxicity of most human sera. However, 15- to 30-fold expression of hDAF was required for effective inhibition of human sera with the highest cytotoxic capacity.
A much higher level of hDAF expression in pig cells than previously considered necessary might be required to provide additional benefit in inhibiting antibody-mediated rejection. Genetically engineered pigs that express very high levels of hDAF would be beneficial for xenotransplantation.
尽管α1,3-半乳糖基转移酶基因敲除(GT-KO)猪的成功培育提高了临床异种移植的期望,但仍在探索对基因工程猪进行更多修饰,因为即使是GT-KO猪也无法完全抑制宿主的免疫反应。一种潜在的候选物是补体调节蛋白,如人衰变加速因子(hDAF)。然而,关于猪细胞中hDAF的表达水平需要多高才能抑制补体激活的报道很少。本研究的目的是探讨hDAF表达水平与其对人血清细胞毒性抑制作用之间的关系。
使用电穿孔系统(Gene Pulser II)将含有hDAF基因的表达载体(pCAGGS)转染到猪成纤维细胞中。转染后48至52小时,用异硫氰酸荧光素(FITC)标记的抗hDAF抗体对细胞进行染色,然后应用于细胞分选仪。通过对荧光强度进行门控,收集具有不同表达水平的hDAF转染细胞。相对于人对照内皮细胞,测定hDAF的表达水平。将表达x1、x5、x10、x15和x30 hDAF的收集细胞接种到96孔板中培养16小时,然后对细胞进行3-(4,5-二甲基-2-噻唑基)-2,5-二苯基溴化四氮唑(MTT)测定。
MTT测定时(分选后16小时)转染细胞中的hDAF表达水平与分选后立即测定的水平相当。猪细胞中hDAF的表达水平比人内皮细胞高五倍时,可有效抑制大多数人血清的补体依赖性细胞毒性。然而,对于具有最高细胞毒性的人血清,需要hDAF表达15至30倍才能有效抑制。
为了在抑制抗体介导的排斥反应中提供额外益处,可能需要猪细胞中hDAF的表达水平比以前认为的必要水平高得多。表达非常高水平hDAF的基因工程猪将有利于异种移植。